Maven Securities LTD Adaptive Biotechnologies Corp Transaction History

Maven Securities LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $16 Million - $29.2 Million	-430,616 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $2.5 Million - $3.64 Million	55,616 Added 14.83%	430,616 $25.6 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $13.4 Million - $18.3 Million	375,000 New	375,000 $18 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $1.33 Million - $2.67 Million	-78,223 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $1.92 Million - $2.57 Million	78,223 New	78,223 $2.34 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $1.59 Million - $2.81 Million	-52,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $2.12 Million - $2.54 Million	52,500 New	52,500 $2.51 Million

187

152M

8.4K

56K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $627M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.